These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 12034170

  • 1. Combined use of FTY720 and cyclosporine A prevents chronic allograft vasculopathy.
    Koshiba T, Van Damme B, Lu Y, Yan Y, Rutgeerts O, Overbergh L, Tanaka K, Waer M, Mathieu C, Pirenne J.
    Transplant Proc; 2002 May; 34(3):748-9. PubMed ID: 12034170
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. FTY720 blocks allograft rejection by homing of lymphocytes in vivo.
    Yuzawa K, Stephkowski SM, Wang M, Kahan BD.
    Transplant Proc; 2000 Mar; 32(2):269. PubMed ID: 10715413
    [No Abstract] [Full Text] [Related]

  • 8. Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft.
    Zhang L, Zhu T, Sun EW, Shen SQ, Min ZL, Chen ZK.
    Transplant Proc; 2003 Feb; 35(1):567-8. PubMed ID: 12591534
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME, Tejpal N, Qu X, Yu J, Okamoto M, Stepkowski SM, Kahan BD.
    Transplantation; 1998 Apr 15; 65(7):899-905. PubMed ID: 9565092
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: implications for therapy of chronic rejection.
    Habicht A, Clarkson MR, Yang J, Henderson J, Brinkmann V, Fernandes S, Jurewicz M, Yuan X, Sayegh MH.
    J Immunol; 2006 Jan 01; 176(1):36-42. PubMed ID: 16365393
    [Abstract] [Full Text] [Related]

  • 13. Effect of a new immunosuppressant, FTY720, on joint allografts.
    Watanabe H, Hamada Y, Toshima T, Nagasawa K, Sakano Y.
    J Reconstr Microsurg; 1999 May 01; 15(4):295-8. PubMed ID: 10363553
    [Abstract] [Full Text] [Related]

  • 14. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of FTY720 on rat small bowel transplantation.
    Fujishiro J, Inoue S, Shimizu H, Yoshino H, Murakami T, Kobayashi E.
    Transplantation; 2004 Jun 27; 77(12):1910-1. PubMed ID: 15223918
    [No Abstract] [Full Text] [Related]

  • 17. Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model.
    Nikolova Z, Hof A, Baumlin Y, Hof RP.
    Transplantation; 2001 Jul 15; 72(1):168-71. PubMed ID: 11468555
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats.
    Yamashita K, Nomura M, Omura T, Takehara M, Suzuki T, Shimamura T, Kishida A, Furukawa H, Murakami M, Uede T, Todo S.
    Transplant Proc; 1999 Jul 15; 31(1-2):1178-9. PubMed ID: 10083526
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.